DKBmed Expands Successful COVID-19 Educational Webinar Series
Nyenta.com/10172954

MANHATTAN, N.Y. - Nyenta -- In response to the evolving needs of health care providers and the recent surge of the Omicron variant DKBmed is expanding its highly successful, educational webinar series on the novel coronavirus entitled COVID-19: Keeping Up with a Moving Target. Since its launch in March 2020, this initiative has reached over 125,000 clinicians worldwide and features more than 100 programs. These webcasts explore a diverse array of topics relevant to health care providers across providers who care for patients at-risk for or who have contracted COVID-19.

DKBmed's COVID-19 Hub with all these programs can be found at covid19.dkbmed.com

Multispecialty webcasts and videos
The DKBmed weekly series of webcasts will continue to cover a wide range of topics for health care providers across all medical specialties who manage patients with COVID-19. These live webcasts will arm providers with the latest guidance and breaking data on COVID-19 treatments for both ambulatory and hospitalized patients.

More on Nyenta.com

• Cornerstone and Swiftlane Announce Strategic Technology Initiative to Create Safer Rental Communities in Denver
• NYC REIT Sends Letter Urging Shareholders to Vote for Company's Incumbent Director Nominee as Annual Meeting Approaches
• TUPPERWARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Tupperware Brands Corporation on Behalf of Tupperware Stockholders and Encourages Investors to Contact the Firm
• The Dog Gurus Collaborate with Blue-9 for Advancement of Dog Daycare Enrichment Programs
• Lindsay Goldberg Completes Sale of Pixelle Specialty Solutions

Treatment Strategies for SARS-CoV-2 Variants
These webinars will focus on the effects of viral variants on viral transmissibility, morbidity, and treatment, and the importance of early intervention, including appropriate management with monoclonal antibodies (mAbs) and other available therapies active against the Omicron variant

Health Equity
These programs will feature extensive information on Inequities in social determinants of health. Several studies have examined the disparities in COVID-19 incidence, morbidity, and mortality. Inequities in social determinants of health likely contribute significantly toward increased risk of exposure to SARS-CoV-2. Clinicians treating people from ethnic and racial minority groups must be kept abreast of new information as it emerges so they can keep up with the moving target that is SARS-CoV-2.

​

Success of COVID-19: Keeping Up with a Moving Target
DKBmed's COVID-19: Keeping Up with a Moving Target program has reached more than 125,000 clinicians worldwide through more than 100 programs.

More on Nyenta.com

• Flower City Days Horticultural at the City of Rochester Public Market Continues on Sunday, May 22
• TOKYO SKYTREE Celebrates Its 10th anniversary! Let's Pay Homage to this Japanese Landmark and World's Tallest Freestanding Broadcast Tower
• Genpact Limited Board Declares Quarterly Cash Dividend
• Yonkers Police Department promotes, appoints five members during Police Week
• Yonkers Mayor Spano Launches Electric Powered Leaf Blower Incentive Program to Help Protect Public Health

The proven impact of these progams and its broad reach demonstrate a sustained need for regular updates on COVID-19 from trusted medical and scientific resources. The ongoing series of webinars and podcasts are freely accessible at any time on DKBmed's Hub website covid19.dkbmed.com.
​

About DKBmed
​DKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.

DKBmed's programs are accessible through the company's website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.